Dr. Julia Marian Kasprzak, MD

Dr. Kasprzak practices at The Medical College of Wisconsin, Inc. in Milwaukee, Wisconsin.

Dr. Kasprzak's NPI, 1023247442, was assigned on July 7, 2009. Dr. Kasprzak holds Wisconsin license 60591.

Dr. Kasprzak's primary practice is The Medical College of Wisconsin, Inc., at 10000 W Innovation Dr, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 955-5990.

Dr. Kasprzak's primary practice is The Medical College of Wisconsin, Inc. in Milwaukee, Wisconsin. Dr. Kasprzak is also affiliated with Froedtert Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Kasprzak to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kasprzak practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Kasprzak's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kasprzak is board certified in dermatology by the American Board of Dermatology. Dr. Kasprzak is licensed in Wisconsin.

CMS data shows 947 Medicare services from Dr. Kasprzak across 16 procedure codes in 2024, for 310 Medicare patients. Medicare paid $127,158 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 310 Medicare patients who saw Dr. Kasprzak in 2024. The largest group is 65 to 74, with 128 patients. 73% of them have high cholesterol, and 68% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kasprzak's median patient age at 75, with 43% women.

In 2024, Dr. Kasprzak wrote 97 Medicare Part D claims for 59 patients. 100% of them were for generic drugs. CMS names the drug for 60 of them, across 3 drugs with 11 or more claims each, at $4,726 in total drug cost. In 2023, CMS named 52 claims across 2 drugs.

Dr. Kasprzak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 46 procedures of melanoma (skin cancer) excision by Dr. Kasprzak, more than 86% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Kasprzak, published from 2015 to 2024. 2024 was the busiest year, with 6. The most frequent topics are Skin Neoplasms and Carcinoma, Squamous Cell. Dr. Kasprzak has published most often in Transl Oncol. Dr. Kasprzak's most frequent co-authors are Monica Erin Shukla, Joseph Zenga, MD and Musaddiq Javvad Awan, MD.

CMS Open Payments shows 2 general payments to Dr. Kasprzak from 2 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $88.